Related Experiment Videos
A splice-site mutation causing ovine McArdle's disease
1Department of Pathology, University of Western Australia, Nedlands, Australia.
Neuromuscular Disorders : NMD
|July 1, 1997
Summary
Researchers identified a genetic mutation causing McArdle's disease in sheep, an exercise intolerance myopathy. This discovery provides an ovine model for developing new therapies for this glycogen storage disease.
Area of Science:
- Genetics
- Molecular Biology
- Animal Models
Background:
- McArdle's disease is an inherited myopathy characterized by exercise intolerance due to muscle glycogen phosphorylase deficiency.
- Understanding the genetic basis of McArdle's disease is crucial for developing therapeutic strategies.
- Previous research has identified human disease-causing mutations.
Purpose of the Study:
- To identify the genetic mutation responsible for an ovine form of McArdle's disease.
- To characterize the molecular defect in affected sheep.
- To establish a valuable animal model for studying McArdle's disease and testing potential treatments.
Main Methods:
- PCR amplification of ovine glycogen myophosphorylase cDNA.
- Single-strand conformation polymorphism (SSCP) analysis to detect sequence variations.
- Sequencing of cDNA fragments and intron 19 to pinpoint the mutation.
- Analysis of splice-site mutation and its effect on protein sequence.
Main Results:
- Identified an eight-base deletion at the 5' end of exon 20 in the glycogen myophosphorylase cDNA of affected sheep.
- This deletion causes a frame-shift and premature stop codon, leading to a truncated protein.
- A splice-site mutation (adenine for guanine substitution at intron 19 3' splice-site) was identified as the genomic cause.
- The mutation eliminated an XbaI restriction site, enabling carrier and affected sheep diagnosis.
Conclusions:
- An ovine model of McArdle's disease has been characterized, linked to a specific splice-site mutation in the glycogen myophosphorylase gene.
- This ovine model provides a platform for preclinical therapeutic trials for McArdle's disease.
- The identified diagnostic marker facilitates genetic screening in sheep populations.